20 set 2021
Sentinel Lymph Node Biopsy in Cutaneous Melanoma-Where Do We Stand?
Sentinel Lymph Node Biopsy in Cutaneous Melanoma-Where Do We Stand?
20 set 2021
Cutaneous adverse events caused by immune checkpoint inhibitors
Immune checkpoint inhibitors (ICIs) have emerged as active therapies for a variety of cancers.
20 set 2021
Ulcus vulvae acutum Lipschütz
The case report literature on ulcus vulvae acutum Lipschütz (UVAL) is scant, and specific guidelines on its diagnosis and treatment are lacking.
13 set 2021
Avviso di convocazione dell’assemblea ordinaria dei soci SIDeMaST 14 ottobre 2021
Si comunica che l’Assemblea dei soci è convocata per giovedì 14 ottobre, alle ore 4.30
13 set 2021
Vitiligo: an update on systemic treatments
Vitiligo is an autoimmune skin condition characterized by depigmented macules and patches, and has a huge psychosocial impact on patients.
13 set 2021
Ocular cicatricial pemphigoid review
Ocular mucous membrane pemphigoid produces progressive cicatrizing conjunctivitis; this can result in scarring of the conjunctiva and cornea.
13 set 2021
Diagnosis and treatment of classic and iatrogenic Kaposi's sarcoma
Kaposi's sarcoma (KS) is a lymphangioproliferative disorder associated with Human herpesvirus 8
08 set 2021
Effetti dei cambiamenti climatici sulla pelle
Al centro del Congresso della Società Italiana di Dermatologia medica, chirurgica, estetica e delle malattie sessualmente trasmesse, in versione digitale dal 13 al 16 ottobre
07 set 2021
In ricordo del Prof. Alfredo Rebora
Cordoglio per la scomparsa del Prof. Rebora (1935-2021)
06 set 2021
Psoriasis exacerbation after COVID-19 vaccination
Psoriasis exacerbation after COVID-19 vaccination
06 set 2021
Drug Survival of IL-12/23, IL-17 and IL-23 Inhibitors for Psoriasis Treatment
Drug survival analysis of biologic agents in psoriasis is of extreme importance
06 set 2021
Predictive factors of lack of response to adalimumab among bio-naive patients
Efficacy of anti-TNF-a agents seems inferior to IL-17 and IL-23 inhibitors.
26 ago 2021
Position statement on Classification of Basal Cell Carcinomas
No simple staging system has emerged for basal cell carcinomas (BCCs)
26 ago 2021
Position statement on classification of basal cell carcinomas
No simple classification system has emerged for 'advanced basal cell carcinomas', and more generally for all difficult-to-treat BCCs
26 ago 2021
Cutaneous squamous cell carcinoma in patients with chronic lymphocytic leukemia
The continuous improvement of life expectancy of patients with chronic lymphocytic leukemia (CLL)
18 ago 2021
Le donne afgane sono le vittime prescelte dalla conquista dei talebani
Sottoscrizione per garantire un corridoio di solidarietà ai tanti cervelli in fuga nel Nostro paese
04 ago 2021
EADV Live Courses are back
We are glad to inform you that after more than one year, the EADV has reopened the registrations to its face-to-face courses
02 ago 2021
Disease characteristics, prognosis, and response to therapy in patients
Mycosis fungoides with large cell transformation (MF-LCT) is associated with an aggressive clinical course yet data comparing treatment outcomes in MF-LCT are sparse.
02 ago 2021
Efficacy and safety of mogamulizumab by patient
Mogamulizumab was compared with vorinostat in the phase 3 MAVORIC trial (NCT01728805) in 372 patients
02 ago 2021
Patch test informed consent form: position statement
To our knowledge, an international consensus is lacking regarding the development of an adequate informed consent form for a patch test (PT) and the information that should be included in such document.